Why the study?
What are the prognostic factors for long-term survival, local recurrence, and pulmonary metastases in patients with synovial sarcoma of the extremity or trunk?
What are the prognostic factors for long-term survival, local recurrence, and pulmonary metastases in patients with synovial sarcoma of the extremity or trunk?
Answers are grounded in this paper and cite their sources.
In patients with synovial sarcoma, age, tumor size, metastasis, metastasis-free period, and center-based treatment are independent prognostic factors for long-term survival.
One hundred and thirteen consecutive patients with synovial sarcoma of the extremity or trunk were studied retrospectively. Seventy-six patients had surgery of their primary tumor at our institution (37 elsewhere). Mean follow-up for survivors was 124 (13-302) months. Thirteen developed local recurrence and 62 pulmonary metastases. Increasing surgical margin, adjuvant radiotherapy, and center-based treatment correlated with better local control. Older age, large tumor size and proximal position on the limb correlated with more metastases. Overall 5- and 10-year survival was 68 and 56%, respectively. Age, size, metastasis, metastasis free period and center-based treatment were independently prognostic.
No takes yet. Share an insight, caveat, or question.
Pritchard et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: